Stockreport

Seres Therapeutics: Reiterating Buy Rating With Price Target Increased To $15 [Seeking Alpha]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Seres Therapeutics: Reiterating Buy Rating With Price Target Increased To $15 [Read more]